Ping An Biomedical (NASDAQ: PASW) CFO Yang Hongli files initial Form 3

Rhea-AI Filing Summary

Ping An Biomedical Co., Ltd. CFO Yang Hongli filed an initial Form 3 as an officer of the company. The filing lists no reportable transactions, and the transaction summary shows zero buys, sells, exercises, gifts, tax withholdings, or restructurings, with derivative positions also not reported.

Key Figures

Buy transactions: 0 transactions Sell transactions: 0 transactions Derivative transactions: 0 transactions +1 more

4 metrics

Buy transactions 0 transactions Form 3 transaction summary

Sell transactions 0 transactions Form 3 transaction summary

Derivative transactions 0 transactions Form 3 derivative transaction count

Net buy/sell direction neutral Form 3 transactionSummary netBuySellDirection

Key Terms

Form 3, reporting person, derivative securities, transaction summary

4 terms

Form 3 regulatory

"The Form 3 reports CFO Yang Hongli’s status as an officer"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

"The reporting person is Yang Hongli, identified as the CFO"

derivative securities financial

"No derivative securities are shown in the summarized data"

Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.

transaction summary financial

"The transaction summary lists zero buys, zero sells"

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Yang Hongli (HLY)

(Last) (First) (Middle)

ROOM 401, UNIT 4, BUILDING 15,

LIUZHUANG NEW VILLAGE, TONGZHOU DISTRICT

(Street)

BEIJING CITY 100000

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
10/14/2025

3. Issuer Name and Ticker or Trading Symbol
Ping An Biomedical Co., Ltd. [ PASW ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Hongli Yang	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Ping An Biomedical (PASW) Form 3 filing report?

The Form 3 reports CFO Yang Hongli’s status as an officer of Ping An Biomedical. It functions as an initial ownership statement and, in this instance, shows no reportable transactions or derivative positions in the summarized data.

Does Ping An Biomedical CFO Yang Hongli buy or sell shares in this Form 3?

No buy or sell activity appears in this Form 3. The transaction summary lists zero buys, zero sells, zero exercises, and no other transaction types, indicating no reportable trading activity in this filing for the CFO.

Are any derivative securities reported in the Ping An Biomedical (PASW) Form 3?

No derivative securities are shown in the summarized data. The derivative transaction count is zero and the derivative summary table is empty, indicating no options, warrants, or other derivative positions reported in this particular Form 3 filing.

Who is the reporting person in the Ping An Biomedical Form 3?

The reporting person is Yang Hongli, identified as the CFO of Ping An Biomedical Co., Ltd. The filing confirms this officer role and indicates Yang is not listed as a director or ten percent owner in the structured data.

What is the significance of a Form 3 for Ping An Biomedical investors?

Form 3 establishes baseline insider ownership information when someone becomes an officer, director, or large shareholder. For Ping An Biomedical, this filing records CFO Yang Hongli’s reporting status, even though no specific share transactions or derivative holdings are reported here.